Nomura Holdings
RIGL icon

Nomura Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

Nomura Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,144
Closed -$65K – 1553
2016
Q1 		$65K Sell
3,144
-1,706
-35% -$42.1K ﹤0.01% 1433
2015
Q4 		$147K Sell
4,850
-2,577
-35% -$78.1K ﹤0.01% 1651
2015
Q3 		$188K Sell
7,427
-3,622
-33% -$108K ﹤0.01% 1429
2015
Q2 		$356K Sell
11,049
-4,445
-29% -$170K ﹤0.01% 1394
2015
Q1 		$550K Buy
15,494
+2,057
+15% +$56.4K ﹤0.01% 1045
2014
Q4 		$317K Buy
+13,437
New +$272K ﹤0.01% 1878
2014
Q2 		– Sell
-1,398
Closed -$54K – 2988
2014
Q1 		$54K Sell
1,398
-833
-37% -$29.7K ﹤0.01% 2584
2013
Q4 		$63K Buy
+2,231
New +$65.5K ﹤0.01% 1869
2013
Q3 		– Sell
-1,162
Closed -$39K – 2556
2013
Q2 		$39K Buy
+1,162
New +$52.7K ﹤0.01% 2088

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings's RIGL Position: Q2 2016 in Review

Nomura Holdings sold out of Rigel Pharmaceuticals (RIGL) in Q2 2016, closing a stake of 3,144 shares — an estimated $65K sold.

Nomura Holdings first reported a position in RIGL in Q2 2013 and held it in 9 quarters. The position peaked at $550K in Q1 2015. 120 funds tracked by Wall St. Rank hold RIGL as of Q2 2016.

  • Nomura Holdings reported no remaining Rigel Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Nomura Holdings sold 3,144 Rigel Pharmaceuticals shares in Q2 2016, an estimated $65K.
  • Nomura Holdings first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Nomura Holdings's Rigel Pharmaceuticals position peaked at $550K in Q1 2015.
  • 120 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.